Please login to the form below

Not currently logged in
Email:
Password:

China

This page shows the latest China news and features for those working in and with pharma, biotech and healthcare.

Is AstraZeneca looking for its next CEO?

Is AstraZeneca looking for its next CEO?

This includes strong growth in China, key approvals for Imfinzi in stage III lung cancer and an expected return to growth in 2018’s Q4 and 2019.

Latest news

More from news
Approximately 95 fully matching, plus 550 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    Finally, Roche has done a second deal with the China‐ based company Ark Biosciences, which specialises in developing treatments for respiratory diseases, this time for worldwide development and commercialisation rights to

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    This reflects the huge opportunity for growth in these products from China in particular. ... We need to make sure that we relocate the leadership to China where most of the growth is coming from.

  • Making Europe a leader in bioscience: boosting trust and opening minds Making Europe a leader in bioscience: boosting trust and opening minds

    to this revolution. These disruptions have reduced classic entry barriers, and the emergence of new big players like China has lowered the new barriers. ... Meanwhile, the emergence of China as an investor in innovation is set to transform the global

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    Mark Mallon is one of the chief architects of AstraZeneca’s current success in China. ... Digital health. So how important will innovations digital health going to be in China?

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    has just achieved a landmark approval in China for its own ‘home-grown’cancer medicine. ... Nevertheless, Oyler observes that the sheer size of China means that there will be room for a number of leading oncology specialists, either multinationals or

More from intelligence
Approximately 14 fully matching, plus 107 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 34 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 14 fully matching, plus 177 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics